1. Home
  2. AVAV vs ABVX Comparison

AVAV vs ABVX Comparison

Compare AVAV & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AeroVironment Inc.

AVAV

AeroVironment Inc.

HOLD

Current Price

$138.20

Market Cap

8.6B

Sector

Industrials

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$97.47

Market Cap

7.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVAV
ABVX
Founded
1971
2013
Country
United States
France
Employees
N/A
69
Industry
Aerospace
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
7.2B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
AVAV
ABVX
Price
$138.20
$97.47
Analyst Decision
Strong Buy
Buy
Analyst Count
17
13
Target Price
$316.88
$131.31
AVG Volume (30 Days)
1.3M
2.8M
Earning Date
03-10-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$135.55
$52.14
Revenue Next Year
$14.90
$4,132.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$135.20
$7.41
52 Week High
$417.86
$148.83

Technical Indicators

Market Signals
Indicator
AVAV
ABVX
Relative Strength Index (RSI) 32.80 43.75
Support Level N/A $87.60
Resistance Level $220.08 $98.59
Average True Range (ATR) 8.96 7.37
MACD -4.51 -0.07
Stochastic Oscillator 6.83 71.13

Price Performance

Historical Comparison
AVAV
ABVX

About AVAV AeroVironment Inc.

AeroVironment Inc supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Company operates in three segments: UxS, LMS, MW.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Share on Social Networks: